The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 3-10B MM: Novel therapeutic approaches

Sun. Oct 14, 2018 9:40 AM - 10:40 AM No.10 (Osaka International Convention Center, 10F 1009)

Chair: Masuzu Ueda (Division of Hematology, Depaertment of Internal Medicine, Jichi Medical University, Japan)

[OS3-10B-5] A novel ER-stress sensor inhibitor, KIRA8, is a potential therapeutic agent for human myeloma cells

Shinobu Tamura1, Yusuke Yamashita1, Shuhei Morita2, Takashi Akamizu2, Takashi Sonoki1 (1.Hematol./Oncol., Wakayama Med. Univ., Wakayama, Japan, 2.First Dep. of Intern. Med., Wakayama Med. Univ., Wakayama, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password